Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial
Open Access
- 30 September 2008
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 8 (1) , 23
- https://doi.org/10.1186/1471-2318-8-23
Abstract
Cost of illness studies show that Parkinson disease (PD) is costly for individuals, the healthcare system and society. The costs of PD include both direct and indirect costs associated with falls and related injuries.Keywords
This publication has 36 references indexed in Scilit:
- Population prevalence and incidence of Parkinson’s disease in an Australian communityInternal Medicine Journal, 2007
- A Review of the Health-Related Quality of Life and Economic Impact of Parkinson??s DiseaseDrugs & Aging, 2006
- Randomised controlled trial of prevention of falls in people aged ≥75 with severe visual impairment: the VIP trialBMJ, 2005
- Apathy in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Burden of parkinsonism: A population‐based studyMovement Disorders, 2002
- Resource use and costs in a Swedish cohort of patients with Parkinson's diseaseMovement Disorders, 2002
- Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson??s DiseasePharmacoEconomics, 1999
- The Economic Impact of Parkinson???s DiseasePharmacoEconomics, 1998
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995
- ParkinsonismNeurology, 1967